As of 2024-12-12, the Intrinsic Value of Generix Group SA (GENX.PA) is
5.73 EUR. This GENX.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 9.70 EUR, the upside of Generix Group SA is
-40.90%.
The range of the Intrinsic Value is 3.30 - 20.57 EUR
GENX.PA Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
DCF (Growth 5y) |
3.30 - 20.57 |
5.73 |
-40.9% |
DCF (Growth 10y) |
4.50 - 26.21 |
7.58 |
-21.9% |
DCF (EBITDA 5y) |
3.69 - 4.56 |
4.16 |
-57.1% |
DCF (EBITDA 10y) |
4.69 - 6.17 |
5.43 |
-44.0% |
Fair Value |
3.76 - 3.76 |
3.76 |
-61.22% |
P/E |
3.96 - 5.68 |
5.02 |
-48.2% |
EV/EBITDA |
3.97 - 7.12 |
5.46 |
-43.8% |
EPV |
5.25 - 7.47 |
6.36 |
-34.4% |
DDM - Stable |
1.96 - 13.97 |
7.97 |
-17.9% |
DDM - Multi |
3.81 - 21.51 |
6.52 |
-32.8% |
GENX.PA Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
219.97 |
Beta |
0.43 |
Outstanding shares (mil) |
22.68 |
Enterprise Value (mil) |
227.24 |
Market risk premium |
5.82% |
Cost of Equity |
6.67% |
Cost of Debt |
5.00% |
WACC |
6.37% |